Pendal Group’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-64,826	Closed	-$1.3M	–	537
2021 Q3	$1.3M	Buy	+64,826	New	+$1.3M	0.01%	292